Company: PSTV
Filing Date: 2025-08-04
Form Type: DRS
Source: 0000950123-25-006916
Chunk: 49

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-04
Form: DRS
Chunk 49
---
 and Rule 506 of Regulation D thereunder, and corresponding provisions of state securities or “blue sky” laws. The March 2025 Purchasers represented that they were acquiring the Securities for investment only and not with a view towards the resale or distribution thereof in violation of the Securities Act. Accordingly, the Securities have not been registered under the Securities Act and such Securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable state securities laws.

| Item 16. | Exhibits and Financial Statement Schedules. |

| (a) | Exhibits. |

The exhibits to the registration statement are listed in the Exhibit Index to this registration statement and are incorporated herein by reference.

| (b) | Financial Statement Schedules. |

Financial statement schedules All schedules have been omitted because either they are not required, are not applicable or the information is otherwise set forth in the financial statements and related notes thereto.

| Item 17. | Undertakings. |

The undersigned registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this 
 registration statement:                                                                                |

| (i) | To include any prospectus required by section 10(a)(3) of the Securities Act of 1933; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement                                                                                                                                         
 (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in    
 volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus 
 filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the                     
 “Calculation of Registration Fee” table in the effective registration statement; and                                                                                                                                                                    |

| (iii) | To include any material information with respect to the plan of distribution not previously disclosed in the 
 registration statement or any material change to such information in the registration statement;             |

provided, however, that paragraphs (a)(1)(i), (a)(1